Breaking down Pfizer’s first quarter earnings results, tariff impacts

Pfizer's (PFE) first quarter earnings were mixed, with sales coming in narrowly below Wall Street expectations. The pharmaceutical company has reaffirmed its 2025 outlook and announced plans for $1.2 billion in cost-cutting efforts, though the company says it's "unable to predict" the impact of US President Trump's tariffs.

Guggenheim Securities senior research analyst and managing director Vamil Divan joins Brad Smith and Madison Mills on Morning Brief to take a closer look at Pfizer's earnings print.

To watch more expert insights and analysis on the latest market action, check out more Morning Brief here: finance.yahoo.com/videos/series/morning-brief/
#youtube #pfizer #pharmaceutical #tariffs #earnings

About Yahoo Finance:

Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.

Get the latest news and data at finance.yahoo.com

Download the Yahoo Finance app on Apple (apple.co/3Rten0R) or Android (bit.ly/3t8UnXO)

Follow Yahoo Finance on social:

X: twitter.com/YahooFinance
Instagram: www.instagram.com/yahoofinance/?hl=en
TikTok: www.tiktok.com/@yahoofinance?lang=en
Facebook: www.facebook.com/yahoofinance/
LinkedIn: www.linkedin.com/company/yahoo-finance